Compare · APP vs TEM
APP vs TEM
Side-by-side comparison of Applovin Corporation (APP) and Tempus AI Inc. (TEM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both APP and TEM operate in Computer Software: Programming Data Processing (Technology), so they compete in similar markets.
- APP is the larger of the two at $87.74B, about 7.1x TEM ($12.40B).
- Over the past year, APP is down 56.1% and TEM is down 28.9% - TEM leads by 27.1 points.
- TEM has been more active in the news (11 items in the past 4 weeks vs 4 for APP).
- Both have 25 recent analyst ratings on file.
PerformanceAPP-56.06%TEM-28.95%
2025-10-16+0.00%2026-10-16
- Company
- Applovin Corporation
- Tempus AI Inc.
- Price
- $266.24-4.65%
- $64.69-9.06%
- Market cap
- $87.74B
- $12.40B
- 1M return
- -17.19%
- -19.45%
- 1Y return
- -56.06%
- -28.95%
- Industry
- Computer Software: Programming Data Processing
- Computer Software: Programming Data Processing
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2024
- News (4w)
- 4
- 11
- Recent ratings
- 25
- 25
APP
Applovin Corporation
AppLovin Corporation engages in building a software-based platform for mobile app developers to enhance the marketing and monetization of their apps worldwide. The company's software solutions include AppDiscovery, a solution to automate, optimize, and manage user acquisition investments for business clients; and MAX, an in-app bidding solution that optimizes purchases of app ad inventory. Its business clients include various advertisers, internet platforms, and others. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
Latest APP
- APP UPCOMING DEADLINE: Levi & Korsinsky Alerts AppLovin Corporation Stockholders of Securities Class Action - Contact the Firm
- Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 16, 2026 in AppLovin Corporation Lawsuit - APP
- AppLovin to Announce Third Quarter 2026 Results
- Levi & Korsinsky Reminds AppLovin Corporation Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 16, 2026 - APP
- Wurl Launches Content Intelligence Platform to Scale Advanced Targeting Across Streaming TV
- The Best Founders in America Oversubscribe Beanstalk 2026, Three Weeks Before Opening
- Adjust: Shopping App Sessions and Installs Climb in First Half of 2026
- Chief Financial Officer (CFO) Stumpf Matthew covered exercise/tax liability with 2,021 shares, decreasing direct ownership by 1% to 175,429 units (SEC Form 4)
- Director Valenzuela Victoria covered exercise/tax liability with 2,730 shares, decreasing direct ownership by 1% to 241,231 units (SEC Form 4)
- CEO Foroughi Arash Adam covered exercise/tax liability with 2,730 shares, decreasing direct ownership by 0.12% to 2,324,954 units (SEC Form 4)
Latest TEM
- Tempus to Report Third Quarter 2026 Financial Results on November 2
- Ambry Genetics Announces GenomeNext™, a Whole Genome Sequencing Test Solution to Improve Diagnosis for Rare Diseases
- Tempus Announces Multi-Year Collaboration with Moderna and Merck
- Amendment: SEC Form S-4/A filed by Tempus AI Inc.
- Tempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026
- CEO, Diagnostics Schoenherr Thomas Edward sold $873,885 worth of shares (10,281 units at $85.00) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 76,740 units (SEC Form 4)
- Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral Regurgitation
- CEO and Chairman Lefkofsky Eric P sold $19,366,630 worth of shares (250,000 units at $77.47) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 144 filed by Tempus AI Inc.
- Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s RNA Foundation Model